Effect of deferiprone on urinary zinc excretion in multiply transfused children with thalassemia major

Indian Pediatrics

Volumn 42, Issue 2, 2005, Pages 150-154

  Bartakke, Sandip ^a   Bavdekar, S B ^a,c   Kondurkar, Pratima ^a   Muranjan, Mamta N ^a   Manglani, Mamata V ^b   Sharma, Ratna ^b  

^a KEM HOSPITAL   (India)

^b LOKMANYA TILAK MUNICIPAL GENERAL HOSPITAL   (India)

^c Worli Seaside CHS Pujari Nagar   (India)

Author keywords

Adverse event; Chelation; Hemosiderosis; Iron

Indexed keywords

DEFERIPRONE; IRON; ZINC;

ARTICLE; BLOOD TRANSFUSION; CHELATION; CHILD; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; INDIA; IRON OVERLOAD; MALE; MALNUTRITION; PROSPECTIVE STUDY; THALASSEMIA MAJOR; URINARY EXCRETION; ZINC DEFICIENCY; ZINC URINE LEVEL;

BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IRON CHELATING AGENTS; MALE; PROSPECTIVE STUDIES; PYRIDONES; RETREATMENT; TIME FACTORS; ZINC;

EID: 14744276326     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Indian Council of Medical Research. Multicentric study to determine β-thalassemia carrier rate in school children in Bombay, Calcutta and Delhi, New Delhi, Indian Council of Medical Research 1991.
2. Edward JB, Patricia JVG. Thalassemia Syndromes. In: Miller DR, Robert LB (Eds.) Blood Diseases of Infancy and Childhood, 7th edition, St. Louis; Mosby; 1990,460-498.
3. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997; 89: 739-761.
4. Cohen AR, Galanello R, Piga A, Dipalma A, Vullo C, Tricta F. Safety profile of the oral chelator deferiprone: A multi-centre study. Br J Hematol 2000; 108: 305-312.
5. Nutrition subcommittee of the Indian Academy of Pediatrics. Report. Indian Pediatrics 1972, 9: 360.
6. Makino T, Saito M, Horiguchi D, Kina K. A highly sensitive colorimetric determination of serum zinc using water soluble pyridylazo dye. Clinical Chimica Acta 1982; 120: 127-135.
7. Hipolito VN, Ananda SP. Vitamins & Trace elements In: Alex CS, Leonard J (Eds.) Gradwohl's Clinical Laboratory Methods and Diagnosis. 8th edition, St. Louis; The C.V. Mosby Company. 1980; p. 376-378.
8. Maclean KH, Cleveland JL, Porter JB. Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes. Blood 2001; 13: 3831-3839.
9. Al-Refaie FN, Wonke B, Hoffbrand AV, Wickens DG, Nortey P, Kontoghiorghes GJ. Efficacy and possible adverse effects of the oral iron chelator 1,2 dimethyl 3-hydroxypyrid- 4- one (L1) in thalassemia major. Blood 1992; 80: 593-599.
10. Lahiri K, Kher A, Rathi S. Zinc: In Health and Disease. In: Gupte S. (Ed.) Recent Advances in pediatrics. Special Volume Nutrition, Growth and Development. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 1997. p. 287-298.